Inventor · disambiguated record
Philip Tan
Also filed as: TAN PHILIP · TAN PHILIP H · TAN PHILIP HUAT SENG
9 granted patents·22 pending applications·54 citations·filing 2004–2024
86Inventor score
Files withAPTEVO RES & DEVELOPMENT LLC5SILVERBACK THERAPEUTICS INC5BLANKENSHIP JOHN W4EMERGENT PRODUCT DEV SEATTLE4TAN PHILIP4
Top patents by PatentIndex Score
31 records- 0194US11179473B2Nectin-4 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Nov 23, 2021·7 cites·30 claims
- 0287US9493564B2CD86 antagonist multi-target binding proteinsTHOMPSON PETER ARMSTRONG·Filed 2009·Granted Nov 15, 2016·12 cites·33 claims
- 0387US8333966B2CD37 immunotherapeutics and uses thereofTAN PHILIP·Filed 2009·Granted Dec 18, 2012·14 cites·4 claims
- 0486US9101609B2CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereofTAN PHILIP·Filed 2009·Granted Aug 11, 2015·13 cites·5 claims
- 0579US9782478B1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES AND DEV LLC·Filed 2017·Granted Oct 10, 2017·4 cites·19 claims
- 0674US10202452B2CD3 binding polypeptidesAPTEVO RES & DEVELOPMENT LLC·Filed 2013·Granted Feb 12, 2019·3 cites·33 claims
- 0771US11352426B2CD3 binding polypeptidesAPTEVO RES & DEVELOPMENT LLC·Filed 2016·Granted Jun 7, 2022·1 cites·37 claims
- 0866US2021095046A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 0965US12364768B2Nectin-4 antibody conjugates and uses thereofARARIS BIOTECH AG·Filed 2021·Granted Jul 22, 2025·0 cites·21 claims
- 1065US11541126B1Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·30 claims
- 1163US2023062712A1Anti-asgr1 antibody conjugates and uses thereofSILVERBACK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1259US2011217302A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2009·Application pending·0 cites
- 1358US2025025074A1Wearable optical e-tattoo for arterial and venous blood oxygenation monitoringUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1456US2018273642A1Heterodimer binding proteins and uses thereofAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1555US2018100021A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1653US2014086903A1Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereofTAN PHILIP·Filed 2013·Application pending·0 cites
- 1753US2014161800A1Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and MethodsBLANKENSHIP JOHN W·Filed 2012·Application pending·0 cites
- 1853US2013195850A1Cd3 immunotherapeutics and uses thereofTAN PHILIP·Filed 2012·Application pending·0 cites
- 1952US2013095097A1Polypeptide Heterodimers and Uses ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
- 2052US2013089554A1RON Binding Constructs and Methods of Use ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
- 2150US2013189261A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
- 2250US2021130473A1TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOFSILVERBACK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2350US2011158995A1Multi-Specific Binding Proteins Targeting B Cell DisordersRENAULT SA·Filed 2009·Application pending·0 cites
- 2446US2015274844A1Heterodimer binding proteins and uses thereofEMERGENT PRODUCT DEV SEATTLE·Filed 2015·Application pending·0 cites
- 2544US2017008960A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2016·Application pending·0 cites
- 2644US2007087984A1Method of identifying agents that inhibit the growth of cancer cellsHU XIUYUAN·Filed 2004·Application pending·0 cites
- 2742US2007184459A1Methods of inhibiting cancer growth by binding to nuclear receptorsIMMUSOL INC·Filed 2006·Application pending·0 cites
- 2841US2019336615A1Tumor targeting conjugates and methods of use thereofSILVERBACK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2940US2017015747A1Cd86 antagonist multi-target binding proteinsAPTEVO RES AND DEV LLC·Filed 2016·Application pending·0 cites
- 3040US2008181892A1Binding Domain Fusion ProteinTRUBION PHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 3137US2013129723A1Heterodimer Binding Proteins and Uses ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →